Basic Information
Basic information for MIR646HG-217-33aa
Peptide Name MIR646HG-217-33aa
Genome Position chr20:60126114-60126212[+]
Species Human
Peptide Sequence MKDGYLPPSKSHRNTSSRWNPNQIPSGKGFWKV
Peptide Length 33
Unique No (MIR646HG-213-33aa,MIR646HG-215-33aa,MIR646HG-222-33aa,MIR646HG-229-33aa,MIR646HG-234-33aa,MIR646HG-246-33aa,MIR646HG-253-33aa,MIR646HG-254-33aa)
Grand Average of Hydropathicity -1.3182
Relative Molecular Mass 4377.79
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000228340;MIR646HG
Transcript ID/Name ENST00000654038;MIR646HG-217
Transcript Length 1422
Coding Ability 0.3319
DNA Sequence Corresponding to Peptide ATGAAGGATGGTTATCTTCCACCTTCCAAATCTCACAGGAACACCTCTTCTAGGTGGAATCCAAACCAGATTCCTTCTGGAAAGGGATTCTGGAAAGTG
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :